Cardiac Output: Quantification of Heart Performance

Background:

The concept of measuring blood flow as a product of the heart’s rate and ejection volume traces back to Adolf Fick in 1870, whose oxygen-consumption method remains the gold standard against which all modern CO measurement techniques are validated.

Cardiac Output (CO) is the volume of blood ejected by the left ventricle per unit time, expressed in liters per minute (L/min).

CO is the product of heart rate (HR) and stroke volume (SV): CO = HR × SV. In a resting 70 kg adult, normal CO is approximately 4–8 L/min, meaning the entire blood volume (~5 L) circulates through the body roughly once per minute.

Operationally, CO represents the heart’s ability to meet the metabolic oxygen demand of various tissues (perfusion). It is the final common pathway through which preload, afterload, contractility, and chronotropy converge into a single number that either sustains perfusion or doesn’t. When any one of those four determinants shifts, CO is the variable that moves.

• CO as an absolute number (L/min): the raw volumetric flow. Useful for comparing a patient’s output over time or against a hemodynamic threshold, but limited because a CO of 5 L/min means something very different in a 50 kg woman versus a 120 kg man.
• Cardiac Index (CI, L/min/m²): CO normalized to body surface area (BSA). A CI of 2.5–4.0 L/min/m² is the accepted normal range. CI is the clinically preferred metric because it accounts for body size and allows meaningful comparison across patients. It is calculated by dividing CO by body surface area.

Determinants:

Cardiac output is governed by four interdependent variables. None of them operate in isolation, each feeds back into the others through pressure-volume relationships, autonomic reflexes, and mechanical coupling. Understanding CO means understanding how these four determinants interact, not just listing them.

Heart Rate (HR) is the simplest lever: all else being equal, doubling HR doubles CO. But “all else equal” never holds in physiology. Beyond ~160 bpm in an adult, diastolic filling time shortens so dramatically that stroke volume drops, and CO actually decreases despite the faster rate. Bradycardia below ~40 bpm reduces CO not because the heart can’t fill, but because there simply isn’t enough ejection cycles per minute. The clinical sweet spot is roughly 60–100 bpm, where filling time and rate are optimally balanced.

Preload is the end-diastolic volume (EDV), the stretch on the myocardial fibers just before contraction. The Frank-Starling mechanism dictates that, within physiologic limits, greater stretch (higher preload) produces greater force of contraction and therefore greater stroke volume. Clinically, preload is manipulated with fluid administration (↑) or diuresis/hemorrhage (↓), and is estimated by central venous pressure (CVP), pulmonary artery occlusion pressure (PAOP), or echocardiographic end-diastolic area.

Afterload is the resistance the ventricle must overcome to eject blood. For the left ventricle, afterload is approximated by systemic vascular resistance (SVR); for the right ventricle, by pulmonary vascular resistance (PVR). The relationship is inverse: ↑ afterload = ↓ stroke volume = ↓ CO. Vasoconstriction (phenylephrine, norepinephrine) raises afterload; vasodilation (nitroglycerin, sevoflurane, neuraxial blockade) lowers it.

Contractility (inotropy) is the intrinsic force-generating ability of the myocardium independent of preload and afterload. Positive inotropes (dobutamine, milrinone, epinephrine) shift the Frank-Starling curve upward — producing a greater stroke volume for the same preload. Negative inotropes (most volatile anesthetics, beta-blockers, calcium channel blockers) shift it downward. Contractility is the hardest determinant to measure directly.

The Frank-Starling curve is the single most important diagram in hemodynamics: it shows that the same preload produces different stroke volumes depending on the contractile state, and it explains why fluid loading helps the hypovolemic patient (ascending limb) but not the failing heart (flat portion of the curve).

Measurement:

In Practice:

Cardiac output is not a fixed property of the patient, it is a moving target shaped by physiology, pharmacology, and the mechanical environment of the thorax at any given moment.

Age reduces resting CO gradually: maximum cardiac output peaks in early adulthood and declines roughly 1% per year after age 30, driven primarily by decreased maximum heart rate (220 − age as crude estimate) and progressive diastolic dysfunction that impairs ventricular filling. An 80-year-old has a resting CO approximately 30–40% lower than a 25-year-old, which has direct implications for drug distribution and anesthetic dosing.

Pregnancy increases CO dramatically: by the third trimester, cardiac output rises 30–50% above non-pregnant baseline, peaking at approximately 6–7 L/min. This is driven by a ~40% increase in blood volume, a 15–20 bpm increase in resting HR, and a significant drop in SVR.

Positive-Pressure Ventilation (PPV) reduces CO by impeding venous return. Spontaneous breathing generates negative intrathoracic pressure that pulls blood into the right atrium; mechanical ventilation reverses this gradient. The effect is dose-dependent: higher PEEP and larger tidal volumes compress the vena cava and right atrium more, reducing preload. In a volume-depleted patient, initiating PPV can drop CO by 20–40%. This is the hemodynamic mechanism behind post intubation hypotension, one of the most common crises in emergency airway management.

Volatile Anesthetics are dose-dependent cardiac depressants. Sevoflurane at 1.0 MAC reduces CO by approximately 10–15% via direct myocardial depression (↓ contractility) and systemic vasodilation (↓ afterload, ↓ preload from vasodilation). Desflurane and isoflurane have slightly less direct myocardial depression but cause more sympathetic activation at higher concentrations.

Sepsis creates a hyperdynamic state early: CO may be elevated to 8–12 L/min despite profound hypotension, because SVR collapses from inflammatory vasodilation while the heart compensates with tachycardia and increased contractility. Late sepsis transitions to a hypodynamic state as myocardial depression (septic cardiomyopathy) supervenes and the ventricle can no longer compensate.

Hypothermia reduces CO approximately 7% per 1°C drop in core temperature, through combined reduction in heart rate (cold-mediated sinus bradycardia), increased SVR (peripheral vasoconstriction), and decreased myocardial contractility.

Limitations

Cardiac output is a global number — it tells you the total flow leaving the left ventricle but says nothing about where that flow goes. A patient with a CO of 6 L/min can still have a critically ischemic gut if mesenteric vasoconstriction is shunting blood elsewhere. This is why CO alone is insufficient for resuscitation endpoints; it must be interpreted alongside markers of regional and microcirculatory perfusion: lactate, mixed venous oxygen saturation (SvO₂), urine output, and capillary refill.

Since CO is a product of two variables (HR × SV), a “normal” CO can mask a pathologic state. A heart rate of 150 bpm with a stroke volume of 35 mL gives the same CO (5.25 L/min) as a heart rate of 70 bpm with a stroke volume of 75 mL, but the first patient is compensating for something, and the compensation will eventually fail. Always decompose CO into its components before deciding that the number is reassuring.